Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: A randomised, double-blind, placebo-controlled, exploratory phase 2 trial

ALD403 study investigators

Research output: Contribution to journal › Article › peer-review

252 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: A randomised, double-blind, placebo-controlled, exploratory phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences